Varun C Dhulipala, MD^1,2, Martine Extermann, MD, PhD^3,4, Najla Al Ali^1*, Jongphil Kim^2,5*, Marina Sehovic, MD, MPH^1*, Tea Reljic^2*, Benjamin Djulbegovic, MD, PhD^1,2 and Jeffrey E Lancet, MD^2,6

¹H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
²University of South Florida, Tampa, FL
³Senior Adult Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁴Department of Oncology Sciences, University of South Florida, Tampa, FL
⁵Department of Biostatistics, Moffitt Cancer Center, Tampa, FL
⁶Malignant Hematology Department, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL

Eveline de Bont, MD, PhD^1*, Ardine Reedijk, MSc^2*, Tim Lammens, PhD^3*, Valerie de Haas, MD, PhD^2*, Barbara Denys, PhD^4*, Laurence Dedeken, MD⁵, Marry van den Heuvel, MD, PhD^6*, Maroeska Loo, MD, PhD^7*, Anne Uyttebroeck^8*, An Vandamme, MD, PhD^9*, Jutte VanderWerff-ten Bosch, MD, PhD^10*, Jozsef Zsiros^11*, Gertjan J.L. Kaspers, MD, PhD¹² and Barbara Moerloose, MD, PhD^13*

¹Department of Pediatric Oncology, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, Netherlands
²Dutch Childhood Oncology Group, Den Haag, Netherlands
³Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium
⁴Department of Clinical Chemistry, Microbiology and Immunology, Ghent University Hospital, Gent, Belgium
⁵Hematology/Oncology, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles, Brussels, Belgium
⁶Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
⁷Department of Pediatric Hematology-Oncology, Radboud University Medical Center, Nijmegen, Netherlands
⁸Department of Pediatrics, University Hospitals Leuven, Leuven, Belgium
⁹Department of Pediatrics, University Hospital Saint-Luc, Brussel, Belgium
¹⁰Department of Pediatrics, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Brussel, Belgium
¹¹Department of Pediatric Oncology, Emma Children's Hospital, Academic Medical Centre, Amsterdam, Netherlands
¹²Department of Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, Netherlands
¹³Department of Pediatric Oncology, Ghent University Hospital, Gent, Belgium

Surbhi Sidana, MD¹, Paul Elson, PhD^2*, Aaron T. Gerds, MD, MS³, Hetty E. Carraway, MD, MBA³, Anjali S. Advani, MD³, Yogen Saunthararajah, M.D.³, Jaroslaw P. Maciejewski, MD, Ph.D.⁴, Matt Kalaycio, MD³, Mikkael A. Sekeres, MD, MS³ and Sudipto Mukherjee, MD, PhD³

¹Department of Hematology and Medical Oncology, Mayo Clinic, Rochester, MN
²Cleveland Clinic, Quantitative Health Sciences, Cleveland, OH
³Leukemia Program, Cleveland Clinic, Cleveland, OH
⁴Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Paul B. Koller, MD¹, Koji Sasaki, MD², Farhad Ravandi, MD³, Guillermo Garcia-Manero, MD³, Susan O'Brien, MD³, Jorge E. Cortes, MD³, Tapan Kadia, MD³, Gautam Borthakur, MD³, Naveen Pemmaraju, MD³, Naval Daver, MD³, Jad Chahoud, MD⁴, Allison Pike, RN^5*, Mark Brandt, BS^6*, Sherry Pierce, BSN, BA^3*, Hagop M. Kantarjian, MD³ and Elias Jabbour³

¹Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴University of Texas Hosuton Health Science Center, Houston, TX
⁵The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX

Yue Gao, PhD^1*, Bin Fan, PhD^2*, Kha Le, PhD^2*, Erika Manyak, BASc^2*, Hua Yang, PhD^2*, Katherine Yen, PhD^2*, Sam Agresta, MD², Eyal C. Attar, MD², Jian Chen, PhD^1*, Qiang Xu, PhD^1*, Alessandra Tosolini, BS^1*, Jay M. Mei, MD, PhD¹, Anjan Thakurta^1*, Robert D. Knight, MD¹ and Yan Li, PhD^1*

¹Celgene Corporation, Summit, NJ
²Agios Pharmaceuticals, Cambridge, MA

Tara L. Lin, MD¹, Laura F. Newell, MD², Robert K. Stuart, MD³, Laura C. Michaelis, MD⁴, Stephen E. Rubenstein, MD⁵, Helen S. Pentikis, Ph.D^6*, Timothy Callahan, Ph.D^7*, Donna Alvarez^8*, Lawrence D. Mayer, PhD^8* and Arthur C. Louie, MD⁸

¹University of Kansas Medical Center, Kansas City, KS
²Center for Hematologic Malignancies, Oregon Health and Science University, Portland, OR
³Medical University of South Carolina, Charleston, SC
⁴Medical College of Wisconsin, Milwaukee, WI
⁵St. Francis Medical Group, Indianapolis, IN
⁶SAJE Consulting, Baltimore, MD
⁷Biomedical Systems, St. Louis, MO
⁸Celator Pharmaceuticals, Inc., Ewing, NJ

Marta Pratcorona^1*, Jordi Lopez-Pardo, MD^1*, Ana Garrido, MD^1*, Salut Brunet, MD, PhD^1*, Josep-Maria Ribera, MD, PhD², Mar Tormo, MD, PhD³, Lourdes Escoda, MD, PhD^4*, Olga Salamero^5*, Montserrat Arnan, MD, PhD^6*, David Gallardo, MD^7*, Joan Bargay, MD^8*, Montserrat Hoyos, phD^1*, Marina Diaz-Beya, MD, PhD^9*, Ruth M Risueño^10*, Josep F. Nomdedeu, MD, PhD^1*, Jorge Sierra, MD, PhD^1* and Jordi Esteve, MD, PhD¹¹

¹Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
²ICO-Hospital Universitari Germans Trias i Pujol, Badalona, Spain
³Hospital Clínico Universitario de Valencia, Valencia, Spain
⁴ICO-Hospital Joan XXIII, Tarragona, Spain
⁵Hospital Universitari Vall d'Hebron, Barcelona, Spain
⁶Institut Català d'Oncologia, Hospital Duran i Reynals, Barcelona, Spain
⁷Hematology Department, ICO-Hospital Josep Trueta, Girona, Spain
⁸Department of Hematology. Hospital Son Llatzer, Palma de Mallorca, Spain
⁹Hematology Department, Hospital Clinic, IDIBAPS Barcelona. Josep Carreras Leukemia Reseach Institute, Barcelona, Spain
¹⁰Institut de recerca contra la leucèmia Josep Carreras, Barcelona, Spain
¹¹Hematology Department, Hospital Clínic, IDIBAPS, Institut Josep Carreras, Barcelona, Spain

Shaun Fleming, MBBS (Hons), FRACP, FRCPA^1*, Doen Ming Ong, MBBS^1*, Kathryn Jackson, MBBS, FRACP, FRCPA^2*, Sharon Avery, MBBS (Hons), FRACP, FRCPA¹, Peter Mollee, MBBS, MMedSc, FRACP, FRCPA³, Paula Marlton, MBBS, FRACP, FRCPA⁴, Glen A Kennedy, MBBS, FRACP, FRCPA^5* and Andrew Wei, MBBS, FRACP, FRCPA, PhD^6,7

¹Department of Haematology, Alfred Hospital, Melbourne, Australia
²Department of Haematology, Nambour General Hospital, Nambour, Australia
³Princess Alexandra Hospital, Brisbane, Australia
⁴Australasian Leukaemia and Lymphoma Group Tissue Bank, Princess Alexandra Hospital, Brisbane, Australia
⁵Department of Haematology, Royal Brisbane and Women's Hospital, Brisbane, Australia
⁶Department of Haematology, The Alfred Hospital, Melbourne, Australia
⁷Australian Centre for Blood Diseases, Monash University, Melbourne, Australia

Cristina Papayannidis, MD, PhD¹, Anna Candoni, MD^2*, Michele Malagola³, Giovanni Marconi, MD^1*, Marco Manfrini, PhD^1*, Giorgia Simonetti, PhD^1*, Elisa Zuffa, PhD^1*, Maria Chiara Abbenante, MD^1*, Sarah Parisi, M.D.^1*, Stefania Paolini^1*, Chiara Sartor^1*, Eugenia Franchini^1*, Emanuela Ottaviani^1*, Claudia Venturi, PhD^1*, Maria Chiara Fontana^1*, Antonella Padella^1*, Viviana Guadagnuolo, PhD^4*, Maria Teresa Bochicchio^1*, Anna Ferrari, PhD^1*, Simona Soverini¹, Nicoletta Testoni^1*, Carmen Baldazzi, PhD^1*, Renato Fanin², Domenico Russo³, Michele Cavo, MD^1* and Giovanni Martinelli, MD, PhD¹

¹Bologna University School of Medicine, Bologna, Italy
²Hematology, Santa Maria della Misericordia University Hospital, Udine, Italy
³Chair of Hematology, Unit of Blood Diseases and Stem Cell Transplantation , University of Brescia, Brescia, Italy
⁴"Seràgnoli" Institute of Hematology, Bologna University School of Medicine, Bologna, Italy

Marta Pratcorona^1*, Ana Garrido, MD^1*, Salut Brunet, MD, PhD^1*, Jordi Esteve, MD, PhD², María Camino Estivill, PhD^1*, M. Paz Queipo De Llano, MD^3*, Susana Vives^4*, Montserrat Arnan, MD, PhD^5*, David Gallardo, MD^6*, Mar Tormo, MD, PhD⁷, Antoni Garcia-Guiñon, MD^8*, Antonia Sampol, MD, PhD^9*, Olga Salamero^10*, Josep Ma Martí, MD^11*, Joan Bargay, MD, PhD^12*, M Carmen Pedro, MD^13*, Montserrat Hoyos, phD^1*, Marina Diaz-Beya, MD, PhD^14*, Lourdes Escoda, MD, PhD^15*, Ramon Guàrdia, MD, PhD^16*, Josep Ribera, MD, PhD¹⁷, Jorge Sierra, MD, PhD^1* and Josep F. Nomdedeu, MD, PhD^1*

¹Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
²Hematology Department, Hospital Clínic, IDIBAPS, Institut Josep Carreras, Barcelona, Spain
³Department of Hematology, Hospital Virgen de la Victoria,, Malaga, Spain
⁴Hospital Universitari Germans Trias i Pujol, Badalona, Spain
⁵Institut Català d'Oncologia, Hospital Duran i Reynals, Barcelona, Spain
⁶Hematology Department, ICO-Hospital Josep Trueta, Girona, Spain
⁷Hospital Clínico Universitario de Valencia, Valencia, Spain
⁸Hematology Department, Hospital Universitari Arnau de Vilanova, Lleida, Spain
⁹Hospital Son Espases, Palma de Mallorca, Spain
¹⁰Hospital Universitari Vall d'Hebron, Barcelona, Spain
¹¹Hematology Department, Hospital Mútua de Terrassa, Barcelona, Spain
¹²Hospital Son Llàtzer, Palma de Mallorca, Spain
¹³Hematology Department, Hospital del Mar, Barcelona, Spain
¹⁴Hematology Department, Hospital Clinic, IDIBAPS Barcelona. Josep Carreras Leukemia Reseach Institute, Barcelona, Spain
¹⁵ICO-Hospital Joan XXIII, Tarragona, Spain
¹⁶ICO- Hospital Josep Trueta, Girona, Spain
¹⁷Department of Hematology, ICO Badalona-Germans Trias i Pujol Hospital. Josep Carreras Leukemia Research Institute. Universitat Autonoma de Barcelona, Badalona, Spain

Lisa Pleyer, MD, DI^1*, Sonja Burgstaller, MD^2*, Reinhard Stauder, MD, MSc^3*, Michael Girschikofsky, MD^4*, Heinz Sill, MD⁵, Konstantin Schlick, MD^1*, Josef Thaler, MD^2*, Britta Halter, MSc^3*, Sigrid Machherndl-Spandl, MD⁴, Armin Zebisch, MD^5*, Angelika Pichler, MD^6*, Michael Pfeilstöcker, MD⁷, Eva-Maria Autzinger, MD^8*, Alois Lang, MD^9*, Klaus Geissler, MD^10*, Daniela Voskova, MD^11*, Dietmar Geissler, MD^12*, Wolfgang R Sperr, MD^13*, Sabine Hojas, MD^14*, Inga Mandac Rogulj, MD^15*, Johannes Andel, MD^16* and Richard Greil, MD¹

¹3rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, Paracelsus Medical University Hospital Salzburg, and Center for Clinical Cancer and Immunology Trials at Salzburg Cancer Research Institute, Salzburg, Austria
²Department of Internal Medicine IV, Klinikum Wels-Grieskirchen, Wels, Austria
³Department of Internal Medicine V, Innsbruck Medical University, Innsbruck, Austria
⁴Department of Hematology and Oncology, Elisabethinen Hospital, Linz, Austria
⁵Department of Hematology, Medical University of Graz, Graz, Austria
⁶Department for Hematology and Oncology, LKH Leoben, Leoben, Austria
⁷3rd Medical Department for Hematology and Oncology, Hanusch Hospital, Vienna, Austria
⁸First Medical Department, Center for Oncology, Hematology and Palliative Care, Wilhelminenspital, Vienna, Austria
⁹Department of Internal Medicine, LKH Feldkirch, Feldkirch, Austria
¹⁰5th Medical Department, Hospital Hietzing, Vienna, Austria
¹¹Department of Internal Medicine III, General Hospital, Linz, Austria
¹²1. Medical department, Klinikum Klagenfurt, Klagenfurt, Austria
¹³Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
¹⁴Department of Internal Medicine, LKH Fürstenfeld, Fürstenfeld, Austria
¹⁵Department of Hematology, Clinical Hospital Merkur, Zagreb, Croatia
¹⁶Department of Internal Medicine II, LKH Steyr, Steyr, Austria

Hiroshi Moritake, MD, PhD¹, Shiro Tanaka, PhD^2*, Hideki Nakayama, MD, PhD^3*, Takako Miyamura, MD, PhD^4*, Shotaro Iwamoto, MD, PhD^5*, Akira Shimada, MD, PhD⁶, Kiminori Terui, MD, PhD^7*, Akiko M. Saito^8*, Norio Shiba, MD, PhD^9*, Yasuhide Hayashi, MD, PhD¹⁰, Daisuke Tomizawa, MD, PhD¹¹, Takashi Taga, MD, PhD^12*, Hiroaki Goto, MD, PhD^13*, Atsushi Manabe, MD, PhD¹⁴, Keizo Horibe, MD, PhD⁸, Shuki Mizutani, MD, PhD^15* and Souichi Adachi, MD, PhD¹⁶

¹Division of Pediatrics, University of Miyazaki, Miyazaki, Japan
²Department of Pharmacoepidemiology, Kyoto University, Kyoto, Japan
³Department of Pediatrics, National Hospital Organization, Fukuoka-Higashi Medical Center, Koga, Japan
⁴Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan
⁵Department of Pediatrics, Mie University Graduate School of Medicine, Tsu, Japan
⁶Pediatrics/Pediatric Hematology & Oncology, Okayama University Hospital, Okayama, Japan
⁷Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
⁸Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
⁹Department of Pediatrics, Gunma University Graduate School of Medicine, Maebashi, Japan
¹⁰Department of Hematology/Oncology, Gunma Children's Medical Center, Shibukawa, Japan
¹¹Division of Leukemia and Lymphoma, Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan
¹²Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan
¹³Division of Hemato-oncology/Regenerative Medicine, Kanagawa Children's Medical Center, Yokohama, Japan
¹⁴Department of Pediatrics, St. Luke's International Hospital, Tokyo, Japan
¹⁵Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Bunkyo-ku, Japan
¹⁶Department of Human Health Sciences, Kyoto University, Kyoto, Japan

Dietger Niederwieser, MD¹, Verena Sophia Hoffmann, Dr.^2*, Utz Krug, MD³, Rainer Krahl, Ph.D^4*, Christina Sauerland, Dipl.-Math^5*, Karsten Spiekermann, MD⁶, Stefan K. Bohlander, MD^7*, Ute Hegenbart, MD^8*, Wolfram Poenisch, MD^1*, Vladan Vucinic, MD^1*, Michael Cross, PhD^9*, Nadja Jaekel, MD^1*, Markus Pfirrmann^10*, Antje Schulze^11*, Alwin Kraemer, MD^12*, Georg Maschmeyer, MD¹³, Christian Junghanss, MD^14*, Sebastian Scholl^15*, Christian Jakob, MD¹³, Thomas Heinicke, MD^16*, Detlev Haehling^17*, Norma Peter, MD^18*, Ute Kreibich, Prof.^19*, Christoph Busemann, MD²⁰, Haifa Kathrin Al-Ali, MD^21*, Ahmet H. Elmaagacli, MD, PhD^22,23*, B Opitz^24*, Hans-Heinrich Wolf, MD^25*, Wolfgang Hiddemann, MD²⁶, Wolfgang E Berdel, MD²⁷ and Thomas Buechner^28*

¹Hematology and Oncology, University of Leipzig, Leipzig, Germany
²Institut für medizinische Informationsverarbeitung, Biometrie und Epidemiologie (IBE), Ludwig-Maximilians-Universität München, Munich, Germany
³Medizinische Klinik A, Universitätsklinikum Münster, Münster, Germany
⁴Department of Hematology and Oncology, University Hospital of Leipzig, Leipzig, Germany
⁵Institut für Biometrie und Klinische Forschung, University Münster, Münster, Germany
⁶Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany
⁷Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand
⁸Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
⁹Division of Hematology and Clinical Oncology, University Hospital Leipzig, Leipzig, Germany
¹⁰Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie (IBE), Ludwig-Maximilians-Universität München, Munich, Germany
¹¹Helios Klinikum, Erfurt, Germany
¹²Department of Internal Medicine V, University Hospital of Heidelberg, Heidelberg, Germany
¹³Department of Hematology, Oncology and Palliative Care, Klinikum Ernst von Bergmann, Potsdam, Germany
¹⁴Department of Medicine III - Hematology/Oncology/Palliative Care, University of Rostock Medical Center, Rostock, Germany
¹⁵University of Jena, Jena, Germany
¹⁶University of Magdeburg, Magdeburg, Germany
¹⁷Haema Onko Schwerin, Schwerin, Germany
¹⁸Internal Medicine, Carl-Thiem-Clinic Cottbus, Cottbus, Germany
¹⁹Klinik für Innere Medizin B, Heinrich-Braun-Krankenhaus, Zwickau, Germany
²⁰Internal Medicine, Hem./Onc., University of Greifswald, Greifswald, Germany
²¹University of Leipzig, Leipzig, Germany
²²Klinik Schwerin, Schwerin, Germany
²³Hematology and Oncology, Hospital Schwerin, Schwerin, Germany
²⁴St. Elisabeth Krankenhaus, Halle, Germany
²⁵Department of Hematology and Oncology, University Hospital, Halle, Germany
²⁶Department of Internal Medicine III, University Hospital Grosshadern, Ludwig-Maximilians-Universität, Munich, Germany
²⁷Department of Medicine A, University Hospital Münster, Muenster, Germany
²⁸Department of Hematology/Oncology, University of Muenster, Muenster, Germany

Andrew Hantel, MD^1*, Niloufer Khan, MD², Richard A. Larson, MD³, Lucy A. Godley, MD, PhD⁴, Michael J. Thirman, MD³, Andrew Artz, MD, MS³, Olatoyosi Odenike, MD³, Hongtao Liu, MD, PhD³, Jane E. Churpek, MD⁴, Darren King, MD^1*, Elizabeth Rich, MD^4*, Kwang Jin Choi, MD^4*, Randall W. Knoebel, PharmD, BCOP^5* and Wendy Stock, MD³

¹Department of Medicine, The University of Chicago Medicine, Chicago, IL
²Departments of Medicine and Pediatrics, The University of Chicago Medicine, Chicago, IL
³University of Chicago Medical Center, Chicago, IL
⁴Department of Medicine, Section of Hematology/Oncology, The University of Chicago Medicine, Chicago, IL
⁵Department of Pharmacy, The University of Chicago Medicine, Chicago, IL

Shuning Wei^1*, Siping Wang^1*, Shaowei Qiu^2*, Junyuan QI^1*, Yingchang Mi, MD, PhD³, Dong Lin, MD, PhD^3*, Chunlin Zhou, MD, PhD^4*, Bingcheng Liu, MD^2*, Ying Wang, MD^5*, Min Wang, MD, PhD^2* and Jianxiang Wang, MD, PhD⁶

¹Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
²Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
³State Key Laboratory of Experimental Hematology, Institute of Hematology & Hospital of Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁴Chinese Academy of Medical Sciences & Peking Union Medical College,Hospital of Blood Diseases, Tianjin, China
⁵State KeInstitute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁶Institute of Hematology, Hospital of Blood Diseases, CAMS, Tianjin, China

Pierre Peterlin, MD^1*, Thierry Guillaume, MD, PhD^1*, Jacques Delaunay, MD^1*, Mohamad Mohty, MD, PhD², Alice Garnier, MD^1*, Fanny Rialland, MD^3*, Marion Strullu, MD^3*, Beatrice Mahe, MD^1*, Viviane Dubruille, MD^1*, Nicolas Blin, MD^1*, Maud Voldoire, MD^1*, Cyrille Touzeau, MD, PHD^1*, Thomas Gastinne, MD^1*, Steven Le Gouill, MD, PhD^1*, Philippe Moreau^1* and Patrice Chevallier, MD, PhD^1*

¹Department of Hematology, Nantes University Hospital, Nantes, France
²Hematology Department, Saint-Antoine Hospital, AP-HP, Universite Pierre et Marie Curie, Paris, France
³Department of Pediatric Hematology, Nantes University Hospital, Nantes, France

Aditi Vedi, MBBS^1,2*, Richard Mitchell, MBBS FRACP^2*, Cecelia Oswald^3*, Glenn M Marshall, MBBS, MD, FRACP⁴, Toby Trahair, MBBS FRACP^3* and David S. Ziegler, MBBS, FRACP, MD²

¹Department of Women and Children's Health, University of New South Wales, Sydney, Australia
²Sydney Children's Hospital, Sydney, Australia
³Kids Cancer Centre, Sydney Children's Hospital, Sydney, Australia
⁴Kids Cancer Centre, Sydney Children's Hospital, Randwick, Australia

Catherine C. Coombs, MD¹, Sean Devlin, PhD^2*, Shweta Dixit, BA^3*, Abhinita Mohanty^4*, Kristina Marie Knapp^5*, Maria Arcila, MD^6*, Virginia M. Klimek, MD¹, Martin S Tallman, MD¹, Ross L. Levine, MD⁷, Raajit K. Rampal, M.D., Ph.D.⁸ and Franck Rapaport, PhD^9*

¹Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
³Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York
⁶Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Memorial Sloan Kettering Cancer Center, New York, NY
⁸Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY
⁹Leukemia Center, Memorial Sloan Kettering Cancer Center, New York City, NY